Component,Publication Grant Number,Publication Doi,Publication Journal,Pubmed Id,Pubmed Url,Publication Title,Publication Year,Publication Keywords,Publication Authors,Publication Abstract,Publication Assay,Publication Tumor Type,Publication Tissue,Publication Dataset Alias,Publication Accessibility,PublicationView_id,Id,entityId
PublicationView,CA232382,10.1016/j.annonc.2023.08.008,Ann Oncol,37777307,https://pubmed.ncbi.nlm.nih.gov/37777307,Treatment of evolving cancers will require dynamic decision support,2023,"Mathematical Modeling, Cancer Ecology And Evolution, Treatment Scheduling","M A R Strobl, J Gallaher, M Robertson-Tessi, J West, A R A Anderson","Cancer research has traditionally focused on developing new agents, but an underexplored question is that of the dose and frequency of existing drugs. Based on the modus operandi established in the early days of chemotherapies, most drugs are administered according to predetermined schedules that seek to deliver the maximum tolerated dose and are only adjusted for toxicity. However, we believe tha(Read more on Pubmed)",Mathematical Modeling,Pan-cancer,Not Applicable,Not Applicable,Open Access,37777307,4dc009c2-0743-4c86-92a4-2eef404fd832,syn52565154
